RB1 and glioblastoma: Mario et al. investigated the impact of specific alterations in tumor suppressor factor (Rb) and oncogene (Ras) on nature kill (NK) cell-mediated cytotoxicity in glioblastoma cell lines injected into severe combined immunodeficiency (SCID) mice through Rb deficiency and mutation [108].